Literature DB >> 24284514

Chronic kidney disease reduces muscle mitochondria and exercise endurance and its exacerbation by dietary protein through inactivation of pyruvate dehydrogenase.

Masanori Tamaki1, Kazutoshi Miyashita1, Shu Wakino1, Masanori Mitsuishi1, Koichi Hayashi1, Hiroshi Itoh1.   

Abstract

Chronic kidney disease impairs physical performance. Here the time course and mechanism of muscle insufficiency in renal failure and the influence of dietary protein were studied using 5/6 nephrectomized C57Bl/6 mice, focusing on muscle mass and mitochondria. A decrease in muscle mitochondria and running distance was found in young (16-20 weeks) 5/6 nephrectomized mice, despite the preservation of muscle volume and power. However, a decrease in muscle volume, associated with a reduction in muscle power, was found in aged (48-52 weeks) 5/6 nephrectomized mice. A high-protein diet feeding from 8 weeks increased muscle volume and power in the mice; but this further decreased running distance. Activation of pyruvate dehydrogenase by dichloroacetate effectively recovered running distance that was decreased by dietary protein. These findings indicate the mechanism of muscle insufficiency in renal failure and suggest that activation of muscle mitochondria would serve as a potential strategy for improving the physical performance of the patients with chronic kidney disease.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24284514     DOI: 10.1038/ki.2013.473

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  46 in total

1.  Changes in skeletal muscle fiber types induced by chronic kidney disease.

Authors:  Stefano Schiaffino; Irene Moretti
Journal:  Kidney Int       Date:  2015-08       Impact factor: 10.612

2.  Impaired skeletal muscle mitochondrial bioenergetics and physical performance in chronic kidney disease.

Authors:  Bryan Kestenbaum; Jorge Gamboa; Sophia Liu; Amir S Ali; Eric Shankland; Thomas Jue; Cecilia Giulivi; Lucas R Smith; Jonathan Himmelfarb; Ian H de Boer; Kevin Conley; Baback Roshanravan
Journal:  JCI Insight       Date:  2020-03-12

Review 3.  Exercise and CKD: Skeletal Muscle Dysfunction and Practical Application of Exercise to Prevent and Treat Physical Impairments in CKD.

Authors:  Baback Roshanravan; Jorge Gamboa; Kenneth Wilund
Journal:  Am J Kidney Dis       Date:  2017-04-18       Impact factor: 8.860

4.  Chronic kidney disease attenuates the plasma metabolome response to insulin.

Authors:  Baback Roshanravan; Leila R Zelnick; Daniel Djucovic; Haiwei Gu; Jessica A Alvarez; Thomas R Ziegler; Jorge L Gamboa; Kristina Utzschneider; Bryan Kestenbaum; Jonathan Himmelfarb; Steven E Kahn; Daniel Raftery; Ian H de Boer
Journal:  JCI Insight       Date:  2018-08-23

Review 5.  Mitophagy: Basic Mechanism and Potential Role in Kidney Diseases.

Authors:  Chengyuan Tang; Liyu He; Jing Liu; Zheng Dong
Journal:  Kidney Dis (Basel)       Date:  2015-04-24

Review 6.  Shared molecular and cellular mechanisms of premature ageing and ageing-associated diseases.

Authors:  Nard Kubben; Tom Misteli
Journal:  Nat Rev Mol Cell Biol       Date:  2017-08-09       Impact factor: 94.444

7.  Gait Speed in Patients With Kidney Failure Treated With Long-term Dialysis.

Authors:  Baback Roshanravan
Journal:  Am J Kidney Dis       Date:  2015-08       Impact factor: 8.860

8.  CKD and Muscle Mitochondrial Energetics.

Authors:  Baback Roshanravan; Bryan Kestenbaum; Jorge Gamboa; Sharon A Jubrias; Ernest Ayers; Laura Curtin; Jonathan Himmelfarb; Ian H de Boer; Kevin E Conley
Journal:  Am J Kidney Dis       Date:  2016-06-14       Impact factor: 8.860

9.  Deficits in the Skeletal Muscle Transcriptome and Mitochondrial Coupling in Progressive Diabetes-Induced CKD Relate to Functional Decline.

Authors:  Daniel C Bittel; Adam J Bittel; Arun S Varadhachary; Terri Pietka; David R Sinacore
Journal:  Diabetes       Date:  2021-02-01       Impact factor: 9.461

10.  Skeletal muscle metabolic responses to physical activity are muscle type specific in a rat model of chronic kidney disease.

Authors:  Keith G Avin; Meghan C Hughes; Neal X Chen; Shruthi Srinivasan; Kalisha D O'Neill; Andrew P Evan; Robert L Bacallao; Michael L Schulte; Ranjani N Moorthi; Debora L Gisch; Christopher G R Perry; Sharon M Moe; Thomas M O'Connell
Journal:  Sci Rep       Date:  2021-05-07       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.